0
No hay productos en el carro de la compra
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > IgG

IgG

Brief Information

Name:Immunoglobulin G
Target Synonym:Immunoglobulin G
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:5
Lastest Research Phase:Approved

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

IGG-LY69-ELISA
 IgG ELISA

Immobilized Human TNF-alpha Protein, His Tag (Cat. No. TNA-H5228) at 2 μg/mL (100 μL/well) can bind Human Monoclonal Anti-TNF-alpha antibody, Human IgG1 (16H5) (Cat. No. TNA-AM494) when detected by HRP conjugated Anti-Human-IgG-Fc Antibody (6F11C8),mAb (Cat. No. IGG-LY69) dilute at 1:10000 (0.0842μg/ml) (QC tested).

IGG-BLY69-ELISA
 IgG ELISA

Immobilized Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG1 (AM359b) (Cat. No. SPD-M265) at 1 μg/mL (100 μL/well) can bind Biotinylated Monoclonal Mouse Anti-Human-IgG Antibody, Mouse IgG1 (6F11C8) (Cat. No. IGG-BLY69) with a linear range of 0.2-16 ng/mL (QC tested).

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Imlifidase Mac-1 Approved Hansamed Inc Idefirix EU Rejection of renal transplantation Hansa Biopharma Ab 2020-08-25 Rejection of renal transplantation; Kidney Diseases; Purpura, Thrombotic Thrombocytopenic; Rejection of organ transplantation; Renal Insufficiency, Chronic; Guillain-Barre Syndrome; Kidney Failure, Chronic Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Ricefidase KJ-103; KJ103 Phase 3 Clinical Shanghai Bao Pharmaceuticals Co Ltd Rejection of renal transplantation; Anti-Glomerular Basement Membrane Disease Details
AT-02 AT-02 Phase 2 Clinical Attralus Inc Immunoglobulin Light-chain Amyloidosis; Amyloidosis Details
BHV-1300 BHV-1300 Phase 1 Clinical Biohaven Pharmaceuticals Inc Arthritis, Rheumatoid Details
HNSA-5487 HNSA 5487; HNSA-5487 Phase 1 Clinical Hansa Biopharma Ab Neoplasms; Autoimmune Diseases Details
Anti-CD33/anti-FcgammaRI bispecific antibody (UCSD) Phase 1 Clinical University Of California San Diego Leukemia, Myeloid, Acute Details

This web search service is supported by Google Inc.

totop
Email
Correo electrónico
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Dejar un mensaje